Fetal liver transplantation: Biology and clinical results

J. L. Touraine, M. G. Roncarolo, R. Bacchetta, D. Raudrant, A. Rebaud, S. Laplace, P. Cesbron, L. Gebuhrer, M. T. Zabot, F. Touraine, D. Frappaz, G. Souillet, C. Vullo

Research output: Contribution to journalArticle

Abstract

Over the last 18 years, we have developed the transplantation of fetal liver cells to treat severe immunodeficiencies, hematological disorders and inborn errors of metabolism. Post-natally, this treatment is successful in two-third of patients and it is therefore very valuable, especially when there is no perfectly matched donor for a bone marrow transplant. Since 1988 we have carried out these fetal liver transplants (FLTs) in utero, immediately after prenatal diagnosis. Engraftment and reconstitution have been obtained, and several advantages appear to be associated with in utero FLT: increased probability of graft take, ideal isolation of the patient (in the maternal uterus) and optimal environment for the differentiation of the transplanted fetal liver cells (in the fetal host).

Original languageEnglish
Pages (from-to)119-122
Number of pages4
JournalBone Marrow Transplantation
Volume11
Issue numberSUPPL. 1
Publication statusPublished - 1993

Fingerprint

Liver Transplantation
Transplants
Liver
Patient Isolation
Inborn Errors Metabolism
Prenatal Diagnosis
Uterus
Bone Marrow
Mothers
Tissue Donors
Therapeutics

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Touraine, J. L., Roncarolo, M. G., Bacchetta, R., Raudrant, D., Rebaud, A., Laplace, S., ... Vullo, C. (1993). Fetal liver transplantation: Biology and clinical results. Bone Marrow Transplantation, 11(SUPPL. 1), 119-122.

Fetal liver transplantation : Biology and clinical results. / Touraine, J. L.; Roncarolo, M. G.; Bacchetta, R.; Raudrant, D.; Rebaud, A.; Laplace, S.; Cesbron, P.; Gebuhrer, L.; Zabot, M. T.; Touraine, F.; Frappaz, D.; Souillet, G.; Vullo, C.

In: Bone Marrow Transplantation, Vol. 11, No. SUPPL. 1, 1993, p. 119-122.

Research output: Contribution to journalArticle

Touraine, JL, Roncarolo, MG, Bacchetta, R, Raudrant, D, Rebaud, A, Laplace, S, Cesbron, P, Gebuhrer, L, Zabot, MT, Touraine, F, Frappaz, D, Souillet, G & Vullo, C 1993, 'Fetal liver transplantation: Biology and clinical results', Bone Marrow Transplantation, vol. 11, no. SUPPL. 1, pp. 119-122.
Touraine JL, Roncarolo MG, Bacchetta R, Raudrant D, Rebaud A, Laplace S et al. Fetal liver transplantation: Biology and clinical results. Bone Marrow Transplantation. 1993;11(SUPPL. 1):119-122.
Touraine, J. L. ; Roncarolo, M. G. ; Bacchetta, R. ; Raudrant, D. ; Rebaud, A. ; Laplace, S. ; Cesbron, P. ; Gebuhrer, L. ; Zabot, M. T. ; Touraine, F. ; Frappaz, D. ; Souillet, G. ; Vullo, C. / Fetal liver transplantation : Biology and clinical results. In: Bone Marrow Transplantation. 1993 ; Vol. 11, No. SUPPL. 1. pp. 119-122.
@article{09a9bf8b2409412c8ddcd6a49c7286ac,
title = "Fetal liver transplantation: Biology and clinical results",
abstract = "Over the last 18 years, we have developed the transplantation of fetal liver cells to treat severe immunodeficiencies, hematological disorders and inborn errors of metabolism. Post-natally, this treatment is successful in two-third of patients and it is therefore very valuable, especially when there is no perfectly matched donor for a bone marrow transplant. Since 1988 we have carried out these fetal liver transplants (FLTs) in utero, immediately after prenatal diagnosis. Engraftment and reconstitution have been obtained, and several advantages appear to be associated with in utero FLT: increased probability of graft take, ideal isolation of the patient (in the maternal uterus) and optimal environment for the differentiation of the transplanted fetal liver cells (in the fetal host).",
author = "Touraine, {J. L.} and Roncarolo, {M. G.} and R. Bacchetta and D. Raudrant and A. Rebaud and S. Laplace and P. Cesbron and L. Gebuhrer and Zabot, {M. T.} and F. Touraine and D. Frappaz and G. Souillet and C. Vullo",
year = "1993",
language = "English",
volume = "11",
pages = "119--122",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Fetal liver transplantation

T2 - Biology and clinical results

AU - Touraine, J. L.

AU - Roncarolo, M. G.

AU - Bacchetta, R.

AU - Raudrant, D.

AU - Rebaud, A.

AU - Laplace, S.

AU - Cesbron, P.

AU - Gebuhrer, L.

AU - Zabot, M. T.

AU - Touraine, F.

AU - Frappaz, D.

AU - Souillet, G.

AU - Vullo, C.

PY - 1993

Y1 - 1993

N2 - Over the last 18 years, we have developed the transplantation of fetal liver cells to treat severe immunodeficiencies, hematological disorders and inborn errors of metabolism. Post-natally, this treatment is successful in two-third of patients and it is therefore very valuable, especially when there is no perfectly matched donor for a bone marrow transplant. Since 1988 we have carried out these fetal liver transplants (FLTs) in utero, immediately after prenatal diagnosis. Engraftment and reconstitution have been obtained, and several advantages appear to be associated with in utero FLT: increased probability of graft take, ideal isolation of the patient (in the maternal uterus) and optimal environment for the differentiation of the transplanted fetal liver cells (in the fetal host).

AB - Over the last 18 years, we have developed the transplantation of fetal liver cells to treat severe immunodeficiencies, hematological disorders and inborn errors of metabolism. Post-natally, this treatment is successful in two-third of patients and it is therefore very valuable, especially when there is no perfectly matched donor for a bone marrow transplant. Since 1988 we have carried out these fetal liver transplants (FLTs) in utero, immediately after prenatal diagnosis. Engraftment and reconstitution have been obtained, and several advantages appear to be associated with in utero FLT: increased probability of graft take, ideal isolation of the patient (in the maternal uterus) and optimal environment for the differentiation of the transplanted fetal liver cells (in the fetal host).

UR - http://www.scopus.com/inward/record.url?scp=0027460465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027460465&partnerID=8YFLogxK

M3 - Article

C2 - 8448534

AN - SCOPUS:0027460465

VL - 11

SP - 119

EP - 122

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - SUPPL. 1

ER -